Alcon has officially completed the deactivation of two algorithms used for CustomCornea treatment of myopia with or without astigmatism, the U.S. Food and Drug Administration announced. The algorithms ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback